Last reviewed · How we verify

NCT06163287: HYDRORES

Hydrogen-Rich Water and Exercise-Related Biomarkers in Men and Women Over 50 Years

Completed NA Last updated 4 December 2024
What this trial tests

NA trial testing Supplement in Aging in 28 participants. Completed in 31 March 2024.

Timeline
1 October 2023
Primary endpoint
31 March 2024
31 March 2024

Quick facts

Lead sponsorUniversity of Novi Sad, Faculty of Sport and Physical Education
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment28
Start date1 October 2023
Primary completion31 March 2024
Estimated completion31 March 2024
Sites1 location across Serbia

Drugs / interventions tested

Conditions studied

Sponsor

University of Novi Sad, Faculty of Sport and Physical Education

Who can join

Adults 50 to 65, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study investigates the impact of consuming hydrogen-rich water over a six-week period on exercise-related biomarkers among individuals aged over 50, both men and women, who undergo a resistance training program. This research aims to discern the potential benefits of hydrogen-infused water consumption concerning exercise-related markers in an aging demographic post-resistance training.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Supplement

Trials testing the same drug.

Other recruiting trials for Aging

Currently open trials in the same condition.

Other University of Novi Sad, Faculty of Sport and Physical Education trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06163287.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing